PGNY Progyny

Progyny and RESOLVE to Honor National Infertility Awareness Week® by Lighting the Empire State Building and Ringing the Nasdaq Stock Market Closing Bell

Progyny and RESOLVE to Honor National Infertility Awareness Week® by Lighting the Empire State Building and Ringing the Nasdaq Stock Market Closing Bell

A fertility benefits leader and national infertility nonprofit association take over New York City to support the millions of people who need family building care

NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, in its capacity as an official partner for National Infertility Awareness Week 2023, and RESOLVE: The National Infertility Association today announced both organizations will light the top of the Empire State Building in orange, the official color for infertility awareness, and ring the Nasdaq Stock Market Closing Bell on Tuesday, April 25, 2023.

National Infertility Awareness Week brings attention to the far-reaching impact of infertility and the struggle that millions of people endure to build their family. With the CDC reporting that one in five married women in the U.S. deal with infertility, Progyny and RESOLVE share a common goal of removing the stigmas and barriers that stand in the way of building families.

“Progyny is honored to play a role in raising awareness of infertility and supporting the millions of people in need of family building services, this week and always. We believe our efforts will be amplified beyond New York City and create a lasting impact globally,” said Pete Anevski, Progyny’s CEO. “As the fertility and family building benefits provider of choice for hundreds of the world’s leading employers, we have already helped tens of thousands of people on their family building journeys and are eager to continue to provide care for those who are struggling to realize their dreams of parenthood.”

To recognize the millions who struggle with infertility, Progyny, RESOLVE, and leading employers who recognize the importance of providing value-based family building care will participate in Nasdaq’s Closing Bell Ceremony on April 25, 2023, from 3:45 P.M. to 4:15 P.M. Eastern Time.

To amplify the message even further, Progyny and RESOLVE, along with fertility advocate, NAACP and Daytime Emmy® award-winning television host, acclaimed pop-vocalist, and founder of the Faith & Familia Foundation, Adrienne Bailon-Houghton, will light the top of the Empire State Building orange to recognize and give voice to the millions of people who struggle to build their families. This will be the second consecutive year the skyline of New York City and the Empire State Building will be lit in honor of National Infertility Awareness Week.

“Having experienced first-hand how difficult it can be to build a family, I am honored to be a part of National Infertility Awareness Week and join Progyny and RESOLVE in bringing awareness to this disease and fighting for access to family building care,” said Adrienne Bailon-Houghton. “The Faith and Familia Foundation was born out of the idea that everyone should be able to receive the support they need when dealing with infertility, and with these two organizations I feel hopeful that we can achieve that dream.”

“RESOLVE would like to thank Progyny for supporting and recognizing National Infertility Awareness Week as an important national movement that brings attention to the barriers millions of people face when trying to build a family,” said Barbara Collura, President/CEO for RESOLVE. “When people, whether in New York City or through social media, see this iconic building lit in our awareness orange and visually recognize their struggles, they will feel seen. When you feel seen, you find a way to use your voice to create change.”

The Closing Bell Ceremony will be webcasted online. If you’d like to view the ceremony live, visit . If you would like to learn more about the Empire State Building, visit .

To learn more about Progyny, visit . To learn more about RESOLVE, visit, .

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit

About RESOLVE: The National Infertility Association

Established in 1974, RESOLVE: The National Infertility Association is a non-profit organization with the only established, nationwide network mandated to promote reproductive health and to ensure equal access to all family building options for the millions of people experiencing infertility or who face barriers to building a family. RESOLVE addresses this public health issue by providing community to these women and men, connecting them with others who can help, empowering them to find resolution and giving voice to their demands for access to all family building options. For more information, visit

For Further Information, Please Contact:

Investors:

James Hart

Media:

Selena Yang 

 



EN
18/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE

Progyny, Inc. Announces Fourth Quarter 2025 Results

Progyny, Inc. Announces Fourth Quarter 2025 Results Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating Cash FlowReturned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent AuthorizationIssues Financial Guidance for 2026, Reflecting Tenth Consecutive Year of Revenue Growth NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, t...

 PRESS RELEASE

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2...

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants ...

 PRESS RELEASE

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morga...

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference Anticipates Fourth Quarter and Full Year Results to Be Slightly Above Previously Provided Financial Guidance NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced that the Company is participating in the 44th Annual JP Morgan Healthcare Conference, where it intends to discuss its updated expectations for the quarter and year ending December 31, 2025. “As the fourth quarter progr...

 PRESS RELEASE

New Men’s Health Research from Progyny Challenges Conventional Beliefs...

New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action 75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to stigma, cost, and other barriers. NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: PGNY), a global leader in family building solutions, today announced exploring experiences and views on fertility. The findings shed light on how men in the U.S. view their role in the fertilit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch